1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Control of Tumor Promotion and Metastatic Progression by Inflammatory Signaling"}],["$","meta","1",{"name":"description","content":"UC San Diego’s Dr. Michael Karin will describe his recent work on the role of inflammatory processes in the development of tumor metastasis. His research in prostate and lung cancer models supports the hypothesis that metastasis is driven not only by genetic alterations in cancer cells, as previously thought, but is also highly dependent on dynamic and reciprocal interactions between cancer cells and inflammatory cells. Inflammatory cells are recruited into tumors to produce pro-metastatic cytokines, which activate critical signaling pathways required for metastasis.

\nFor additional information, visit: http://www.nidcr.nih.gov/NewsAndFeatures/Announcements/Karin.htm "}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Control of Tumor Promotion and Metastatic Progression by Inflammatory Signaling"}],["$","meta","4",{"property":"og:description","content":"UC San Diego’s Dr. Michael Karin will describe his recent work on the role of inflammatory processes in the development of tumor metastasis. His research in prostate and lung cancer models supports the hypothesis that metastasis is driven not only by genetic alterations in cancer cells, as previously thought, but is also highly dependent on dynamic and reciprocal interactions between cancer cells and inflammatory cells. Inflammatory cells are recruited into tumors to produce pro-metastatic cytokines, which activate critical signaling pathways required for metastasis.

\nFor additional information, visit: http://www.nidcr.nih.gov/NewsAndFeatures/Announcements/Karin.htm "}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/9de49b60-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/b2bc1ab2-580e-43dc-8801-68738945ba5e.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Control of Tumor Promotion and Metastatic Progression by Inflammatory Signaling"}],["$","meta","11",{"name":"twitter:description","content":"UC San Diego’s Dr. Michael Karin will describe his recent work on the role of inflammatory processes in the development of tumor metastasis. His research in prostate and lung cancer models supports the hypothesis that metastasis is driven not only by genetic alterations in cancer cells, as previously thought, but is also highly dependent on dynamic and reciprocal interactions between cancer cells and inflammatory cells. Inflammatory cells are recruited into tumors to produce pro-metastatic cytokines, which activate critical signaling pathways required for metastasis.

\nFor additional information, visit: http://www.nidcr.nih.gov/NewsAndFeatures/Announcements/Karin.htm "}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}